On the recordSeptember 18, 2014
A combination of barriers, including, of course, the high cost of drug development and the small profit margins have helped to drive companies out of the anti-infectious space.
Source
congress.gov“A combination of barriers, including, of course, the high cost of drug development and the small profit margins have helped to drive companies out of the anti-infectious space.”
Barton discusses challenges in antibiotic drug development.
Share
More from Joe Barton
You can tell that you have been president of a national organization. I am throwing you softballs, and you are being very ecumenical.
Thank you, Mr. Chairman, and I want to thank you, sir, for appearing voluntarily without subpoena and standing or sitting there all by yourself.
I thank the gentlewoman from Michigan for her kind words. I appreciate the nice gift I got yesterday from her and her husband, his new book, ``The Dean.'' I look forward to reading it over Christmas. Mr. Speaker, I yield 1 minute to the…
Other voices in this conversation